HB 1675 addresses the corporate practice of medicine and is aimed at limiting non-licensed entities from controlling medical decision-making. The bill adds multiple new sections to Washington law to prohibit corporations, partnerships, management services organizations, and other unlicensed entities from owning or operating medical practices in ways that interfere with licensed health care providers’ professional judgment. It also requires that, in professional service corporations formed for medical practice, licensed providers hold a majority of voting shares, be a majority of directors, and hold most officer positions, with meaningful ownership and active involvement in the practice.
The bill further bars shareholder-directors and officers from transferring de facto control over clinical or administrative functions that could affect patient care, including hiring and firing, scheduling, compensation, billing policies, pricing, and contracting with payors. Separate provisions extend similar anti-interference rules to hospitals, private establishments, ambulatory surgical facilities, nursing homes, birthing centers, and hospice agencies, making it unlawful for unlicensed persons affiliated with those facilities to direct or control a licensed provider’s clinical judgment or patient-care decisions. The bill also amends disciplinary and licensing provisions to require applicants and renewals to attest that they are aware of the new corporate-practice rules.
In addition to the ownership and control restrictions, HB 1675 expands the list of unprofessional conduct for licensed health professionals. It adds or clarifies grounds for discipline related to moral turpitude, false advertising, malpractice, license suspension elsewhere, improper controlled-substance use, violations of health-profession laws and rules, failure to cooperate with disciplinary authorities, aiding unlicensed practice, fraud, inadequate supervision, and other misconduct. It also includes specific prohibitions on interference with investigations, abuse of patients, sexual contact with patients, and certain conflicts of interest or improper treatment practices.
The overall sentiment reflected by the bill text is strongly protective of clinician independence and patient care, with the measure framed as a response to concerns about corporate or managerial influence over medical judgment. Because there are no committee transcripts or recorded votes in the provided material, there is no direct evidence of floor or committee debate, but the structure of the bill suggests a policy preference for physician-led governance and tighter limits on management companies and facility administrators. The bill appears designed to reassure health professionals that clinical decisions remain with licensed providers rather than business entities.
The main point of contention likely centers on the scope of the restrictions and how broadly “interference” or “control” is defined. The bill reaches beyond traditional physician-owned practices to hospitals and other licensed facilities, and it restricts a wide range of operational decisions that could be viewed as business management rather than clinical practice. Supporters would likely see these provisions as necessary to prevent corporate influence over care, while opponents may argue they could limit modern health care business arrangements, management contracts, and operational flexibility for health systems and affiliated organizations.
HB 1675 would substantially expand Washington’s statutory restrictions on the corporate practice of medicine by creating new prohibitions on unlicensed ownership, control, and interference in medical practices and certain health care facilities. It would also amend professional discipline statutes to add new categories of unprofessional conduct and require license applicants and renewals to acknowledge the corporate-practice rules. The bill would affect physicians, other licensed health care providers, professional service corporations, management services organizations, hospitals, private medical facilities, ambulatory surgical centers, nursing homes, birthing centers, hospice agencies, and related entities.
No committee transcripts or vote history were provided, so there is no recorded debate or roll-call sentiment to summarize. Based on the bill’s content, the measure appears to be driven by concern over corporate influence in medicine and to have a protective, provider-centered policy orientation. The text suggests support for preserving clinical autonomy and skepticism toward non-licensed entities directing care.
The likely contention is over how far the state should go in limiting business arrangements in health care. The bill prohibits a broad range of actions that could be interpreted as managerial control, including staffing, scheduling, billing, pricing, and contracting decisions when they affect clinical judgment. Supporters would likely argue these limits are needed to protect patient care and professional independence, while critics may view them as overly expansive, potentially disruptive to hospital and practice management, and difficult to apply in modern integrated health systems.